QUANTUM GENOMICS SAS-REGR (ALQGC.PA) Fundamental Analysis & Valuation

EPA:ALQGC • FR0011648971

Current stock price

0.0721 EUR
0 (-1.77%)
Last:

This ALQGC.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALQGC.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALQGC has reported negative net income.
  • ALQGC had negative earnings in each of the past 5 years.
  • ALQGC had a negative operating cash flow in each of the past 5 years.
ALQGC.PA Yearly Net Income VS EBIT VS OCF VS FCFALQGC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

  • With a Return On Assets value of -84.63%, ALQGC is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
  • ALQGC's Return On Equity of -726.18% is on the low side compared to the rest of the industry. ALQGC is outperformed by 75.71% of its industry peers.
Industry RankSector Rank
ROA -84.63%
ROE -726.18%
ROIC N/A
ROA(3y)-87.78%
ROA(5y)-71.29%
ROE(3y)-517.57%
ROE(5y)-335.54%
ROIC(3y)N/A
ROIC(5y)N/A
ALQGC.PA Yearly ROA, ROE, ROICALQGC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ALQGC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALQGC.PA Yearly Profit, Operating, Gross MarginsALQGC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALQGC.PA Health Analysis

2.1 Basic Checks

  • ALQGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALQGC has about the same amount of shares outstanding.
  • ALQGC has a worse debt/assets ratio than last year.
ALQGC.PA Yearly Shares OutstandingALQGC.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ALQGC.PA Yearly Total Debt VS Total AssetsALQGC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

  • ALQGC has an Altman-Z score of -11.61. This is a bad value and indicates that ALQGC is not financially healthy and even has some risk of bankruptcy.
  • ALQGC has a Altman-Z score of -11.61. This is amonst the worse of the industry: ALQGC underperforms 84.29% of its industry peers.
  • ALQGC has a Debt/Equity ratio of 4.49. This is a high value indicating a heavy dependency on external financing.
  • ALQGC has a worse Debt to Equity ratio (4.49) than 72.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Altman-Z -11.61
ROIC/WACCN/A
WACC7.48%
ALQGC.PA Yearly LT Debt VS Equity VS FCFALQGC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 2.73 indicates that ALQGC has no problem at all paying its short term obligations.
  • The Current ratio of ALQGC (2.73) is comparable to the rest of the industry.
  • A Quick Ratio of 2.73 indicates that ALQGC has no problem at all paying its short term obligations.
  • ALQGC has a Quick ratio of 2.73. This is comparable to the rest of the industry: ALQGC outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73
ALQGC.PA Yearly Current Assets VS Current LiabilitesALQGC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ALQGC.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 87.28% over the past year.
  • The Revenue for ALQGC has decreased by -98.34% in the past year. This is quite bad
  • The Revenue for ALQGC have been decreasing by -79.70% on average. This is quite bad
EPS 1Y (TTM)87.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.58%
Revenue 1Y (TTM)-98.34%
Revenue growth 3Y-79.7%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6121.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1744.53%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALQGC.PA Yearly Revenue VS EstimatesALQGC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALQGC.PA Yearly EPS VS EstimatesALQGC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALQGC.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALQGC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 0.02, which indicates a rather cheap valuation of ALQGC.
  • Based on the Price/Forward Earnings ratio, ALQGC is valued cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.84, ALQGC is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.02
ALQGC.PA Price Earnings VS Forward Price EarningsALQGC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALQGC.PA Per share dataALQGC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • ALQGC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALQGC.PA Dividend Analysis

5.1 Amount

  • ALQGC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ALQGC.PA Fundamentals: All Metrics, Ratios and Statistics

QUANTUM GENOMICS SAS-REGR

EPA:ALQGC (10/24/2024, 7:00:00 PM)

0.0721

0 (-1.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-22
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.00M
Revenue(TTM)10.06K
Net Income(TTM)-3.17M
Analysts34.29
Price Target10.2 (14047.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.02
P/S 496.96
P/FCF N/A
P/OCF N/A
P/B 11.45
P/tB 11.45
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)4.34
Fwd EY6021.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -84.63%
ROE -726.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.78%
ROA(5y)-71.29%
ROE(3y)-517.57%
ROE(5y)-335.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z -11.61
F-ScoreN/A
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.58%
EPS Next Y6121.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-98.34%
Revenue growth 3Y-79.7%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1744.53%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y89.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3919.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

QUANTUM GENOMICS SAS-REGR / ALQGC.PA Fundamental Analysis FAQ

What is the fundamental rating for ALQGC stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALQGC.PA.


What is the valuation status of QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to QUANTUM GENOMICS SAS-REGR (ALQGC.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for QUANTUM GENOMICS SAS-REGR?

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) has a profitability rating of 0 / 10.


How financially healthy is QUANTUM GENOMICS SAS-REGR?

The financial health rating of QUANTUM GENOMICS SAS-REGR (ALQGC.PA) is 3 / 10.


What is the expected EPS growth for QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock?

The Earnings per Share (EPS) of QUANTUM GENOMICS SAS-REGR (ALQGC.PA) is expected to grow by 6121.43% in the next year.